IIN IntriCon

IntriCon Appoints Heather Rider to its Board of Directors

IntriCon Appoints Heather Rider to its Board of Directors

ARDEN HILLS, Minn., March 19, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced the appointment of Heather Rider to the company’s Board of Directors, effective March 20, 2020.

“I am delighted to welcome Heather to our board of directors,” said Mark Gorder, president and chief executive officer of IntriCon. “One of the top priorities we identified for 2020 is to implement an organizational structure that best aligns with our focus on driving a sustainable pipeline of growth opportunities. Heather has the ideal background given her rich experience guiding successful medical technology companies and we are confident she can immediately add valuable insights that will help us achieve our goals.”

Ms. Rider's experience includes more than 30 years as a leader in global human resources for the medical technology industry. She is currently a Director of Inogen Inc. and serves as Chair, Compensation, Nominating and Governance Committee. Her career includes executive level positions with medical device companies such as Intuitive Surgical, Inc. and Alphatec Spine, Inc. She also served in leadership roles in the human resources organizations of Sunrise Medical and Biosense Webster, a member of the J & J family of companies. Most recently, Ms. Rider was vice president of global human resources for Cymer, Inc., the leader in developing light sources used by chipmakers worldwide to pattern advanced semiconductor chips.

“Seeking Board diversity has been another important goal at IntriCon and we are pleased to be driving this initiative forward as we welcome Heather to the leadership team,” said Philip Smith, Chair of the Board of Directors.  “Heather has an excellent record of accomplishment in domestic and international human resource practices, organization change, mergers and acquisitions and site operations management.  Her skills will be highly complementary to our existing Board.”

“It is great a privilege to join IntriCon and I look forward to working with my fellow board members and the company’s leadership team to contribute to its future growth and success,” said Heather Rider. “The future at IntriCon is very exciting as the growing need for micro-miniature body-worn devices presents many exciting opportunities to increase the quality of life for patients.”  

About IntriCon Corporation

Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature and micro-miniature body-worn devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better connected devices. IntriCon has facilities in the United States, Asia and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market. For more information about IntriCon, visit .

Investor Relations Contact:

Leigh Salvo

(415) 937-5404

EN
19/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IntriCon

 PRESS RELEASE

Intricon Announces Completion of Acquisition by an Affiliate of Altari...

Intricon Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners Investment by Altaris Supports Intricon’s Ability to Deliver Innovative Solutions and Service to its Customers ARDEN HILLS, Minn., May 24, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced the completion of its acquisition by funds affiliated with Altaris Capital Partners, LLC (toget...

 PRESS RELEASE

Intricon Reports Fourth Quarter and Full Year 2021 Results

Intricon Reports Fourth Quarter and Full Year 2021 Results ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its fourth quarter and year ended December 31, 2021. Fourth Quarter Highlights: Revenue of $32.2 million compared to $30.3 million in the prior year period Diabetes revenue increased 2% compared to the prior year...

 PRESS RELEASE

Intricon Enters into Agreement to be Acquired by an Affiliate of Altar...

Intricon Enters into Agreement to be Acquired by an Affiliate of Altaris Capital Partners for $241 Million Intricon Shareholders to Receive $24.25 Per Share in Cash ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced that it has entered into a definitive agreement whereby an affiliate of Altaris Capital Partners, LLC (collectively with its affi...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: January 29, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: January 24, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch